This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Eiff, C.
Right arrow Articles by Peters, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Eiff, C.
Right arrow Articles by Peters, G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2003, p. 3613-3615, Vol. 47, No. 11
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.11.3613-3615.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

In Vitro Activity of Recombinant Lysostaphin against Staphylococcus aureus Isolates from Anterior Nares and Blood

Christof von Eiff,1* John F. Kokai-Kun,2 Karsten Becker,1 and Georg Peters1

Institute of Medical Microbiology, University of Münster Hospital and Clinics, 48149 Münster, Germany,1 Department of Microbiology, Biosynexus Incorporated, Gaithersburg, Maryland2

Received 7 May 2003/ Returned for modification 9 June 2003/ Accepted 25 July 2003

The in vitro activity of recombinant lysostaphin was tested against a collection of well-characterized clinical Staphylococcus aureus isolates by disk diffusion (429 isolates) and minimum bactericidal concentration (10 isolates) assays. Minimum bactericidal concentrations of 0.16 µg/ml and zones of inhibition ranging between 15 and 21 mm in diameter demonstrate that lysostaphin was highly active against all isolates tested.

* Corresponding author. Mailing address: Institute of Medical Microbiology, University of Münster Hospital and Clinics, Domagkstraße 10, 48149 Münster, Germany. Phone: 49-251-835-5360. Fax: 49-251-835-5350. E-mail: eiffc{at}uni-muenster.de.

Antimicrobial Agents and Chemotherapy, November 2003, p. 3613-3615, Vol. 47, No. 11
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.11.3613-3615.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Kokai-Kun, J. F., Chanturiya, T., Mond, J. J. (2007). Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model. J Antimicrob Chemother 60: 1051-1059 [Abstract] [Full Text]  
  • El-Baradei, G., Delacroix-Buchet, A., Ogier, J.-C. (2007). Biodiversity of Bacterial Ecosystems in Traditional Egyptian Domiati Cheese. Appl. Environ. Microbiol. 73: 1248-1255 [Abstract] [Full Text]  
  • Yang, X.-Y., Li, C.-R., Lou, R.-H., Wang, Y.-M., Zhang, W.-X., Chen, H.-Z., Huang, Q.-S., Han, Y.-X., Jiang, J.-D., You, X.-F. (2007). In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China. J Med Microbiol 56: 71-76 [Abstract] [Full Text]  
  • Kusuma, C. M., Kokai-Kun, J. F. (2005). Comparison of Four Methods for Determining Lysostaphin Susceptibility of Various Strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 49: 3256-3263 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»